Immune cell cryopreservation liquid, and preparation method, cryopreservation method and application thereof

A technology of immune cells and cryopreservation method, applied in the field of cell preservation, can solve the problems of reducing the possibility of animal pathogen contamination, low survival rate of immune cells in frozen liquid, etc., to protect from freezing damage, maintain physiological functions and biological functions , Good freezing effect

Inactive Publication Date: 2018-03-13
广州市金航生物科技有限公司
View PDF4 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the cryopreservation solution commonly used in China is basically DMSO, human donor serum, and immune cell basal medium. For example, CN104026118A discloses a kind of immune cell cryopreservation solution, its preparation method and application. Made of 10% dimethyl sulfoxide, 10% human donor plasma and 80% opT

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immune cell cryopreservation liquid, and preparation method, cryopreservation method and application thereof
  • Immune cell cryopreservation liquid, and preparation method, cryopreservation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1 The composition of immune cell cryopreservation liquid

[0028] By weight: 5% DMSO, 8% propylene glycol, 6% trehalose, 8% methylcellulose, 0.3% glutathione, 0.06% sodium pyruvate, 72.64% human donor plasma.

Embodiment 2

[0029] Example 2 Composition of Immune Cell Cryopreservation Solution

[0030] By weight: 12% DMSO, 4% propylene glycol, 6% trehalose, 7% methylcellulose, 1% glutathione, 0.12% sodium pyruvate, 69.88% human donor plasma.

Embodiment 3

[0031] Example 3 Composition of Immune Cell Cryopreservation Solution

[0032] By weight: 10% DMSO, 3% propylene glycol, 5% trehalose, 6% methylcellulose, 0.8% glutathione, 0.1% sodium pyruvate, 75.1% human donor plasma.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an immune cell cryopreservation liquid, and a preparation method, a cryopreservation method and an application thereof; the immune cell cryopreservation liquid includes the components by weight: 5%-15% of DMSO, 1%-5% of propylene glycol, 2%-8% of trehalose, 3%-8% of methyl cellulose, 0.3%-1.2% of glutathione, 0.06%-0.14% of sodium pyruvate, and 60%-80% of human donor plasma; the cryopreservation effect is quite good, the immune cells can be effectively protected from freezing injury, physiological functions and biological characteristics of the immune cells after resuscitation are maintained, cell biological characteristics are not changed, and the immune cell cryopreservation liquid can be used in clinical treatment; the immune cell cryopreservation liquid is suitable for long-term frozen preservation of human mononuclear cells and other kinds of immune cells.

Description

technical field [0001] The invention belongs to the technical field of cell preservation, and in particular relates to an immune cell cryopreservation solution, its preparation method, cryopreservation method and application. Background technique [0002] In recent years, immunotherapy techniques for tumors and viruses have been gradually applied clinically. Such as tumor vaccines and adoptive immunotherapy, these methods mainly improve the immunity of patients through in vitro stimulation, culture, expansion and reinfusion of autologous immune cells. At present, such cells mainly include dendritic cells (DC), cells Factor-induced killer cells (CIK), natural killer cells (NK), dendritic cell-induced killer cells (DC-CIK), chimeric antigen receptor T cells (CAR-T), etc. The initial cell sources of these induced and expanded immune cells are mononuclear cells from peripheral blood or umbilical cord blood, and they are directly isolated and cultured. [0003] As the age incre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A01N1/02
CPCA01N1/0221A01N1/0226
Inventor 何跃麦志国肖秀丽袁静娜何炳坤李维维李结珍来从显
Owner 广州市金航生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products